Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline
Go back to Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline| (NASDAQ: HARP) | Delayed: 23.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.01 | 52 Week High | $ | |||
| Open | $1.47 | 52 Week Low | $ | |||
| Day High | $23.01 | P/E | N/A | |||
| Day Low | $23.01 | EPS | $ | |||
| Volume | 27,454 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 152.20 +17.03 (12.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.17 | 52 Week High | $65.46 | |||
| Open | $146.94 | 52 Week Low | $47.97 | |||
| Day High | $153.50 | P/E | 103.54 | |||
| Day Low | $144.90 | EPS | $1.47 | |||
| Volume | 32,411,088 | |||||
